US FDA approves Arcutis' drug to treat chronic skin disease
Dec 15 (Reuters) - The U.S. Food and Drug Administration (FDA) on Friday approved Arcutis Biotherapeutics' drug for treating a skin condition called seborrheic dermatitis in individuals nine years of age and older.
(Reporting by Pratik Jain in Bengaluru; Editing by Shailesh Kuber)